ACIU - AC Immune Ltd - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $12.6. This is a potential upside of $9.91 (368.4%) from yesterday's end of day stock price of $2.69.

AC Immune Ltd's activity chart (see below) currently has 7 price targets and 10 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 13-Nov-2023. First documented stock forecast 12-Nov-2018.

Best performing analysts who are covering ACIU - AC Immune Ltd:

Marc Goodman Andrew Fein

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$16

$12.29 (331.27%)

$16

1 years 1 months 11 days ago
(13-Nov-2023)

0/3 (0%)

$13.1 (451.72%)

Buy

$10

$7.32 (273.13%)

2 years 5 months 12 days ago
(11-Jul-2022)

0/4 (0%)

$6.71 (203.95%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACIU (AC Immune Ltd) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ACIU (AC Immune Ltd) with a proven track record?

MARC GOODMAN

Which analyst has the current lower performing score on ACIU (AC Immune Ltd) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on ACIU (AC Immune Ltd)?

Marc Goodman works at LEERINK and has 9 price targets and 7 ratings on ACIU

Which analyst is the currently most bullish on ACIU (AC Immune Ltd)?

Andrew Fein with highest potential upside - $12.29

Which analyst is the currently most reserved on ACIU (AC Immune Ltd)?

Marc Goodman with lowest potential downside - $7.32

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?